ARCHIVES

In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

DCPC Suggest Options For Encouraging New Minority Centers

May 4, 1984

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

NCI to Get 43 Out Of 200 New Aids Positions, 15 Others; Roper Says That’s “Fair”

November 11, 1988

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004